Upgrade to SI Premium - Free Trial

Arcus Biosciences (RCUS)

22.97 -0.78 (3.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Arcus Biosciences (RCUS) PT Raised to $41 at Truist Securities October 21, 2026 7:05 AM - StreetInsider Citi raises Arcus Biosciences price target to $50 October 21, 2026 3:56 AM - StreetInsider Arcus Biosciences (RCUS) PT Raised to $49 at Wedbush October 20, 2026 1:32 PM - StreetInsider Arcus stock tumbles 6% after unveiling casdatifan trial data October 20, 2026 9:12 AM - StreetInsider Form 8-K Arcus Biosciences, Inc. For: Oct 20 October 20, 2026 8:33 AM - SEC Filing Arcus shares kidney cancer trial data for casdatifan drug October 20, 2026 8:31 AM - StreetInsider Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer October 20, 2026 8:30 AM - BizWire William Blair Starts Arcus Biosciences (RCUS) at Outperform October 16, 2026 3:14 AM - StreetInsider JPMorgan Starts Arcus Biosciences (RCUS) at Overweight October 14, 2026 2:51 AM - StreetInsider Arcus Biosciences Announces New Employment Inducement Grants October 9, 2026 4:35 PM - BizWire Form CT ORDER Arcus Biosciences, Inc. September 28, 2026 2:21 PM - SEC Filing Arcus Biosciences Announces New Employment Inducement Grants September 24, 2026 4:35 PM - BizWire Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy September 22, 2026 8:30 AM - BizWire Arcus Biosciences (RCUS) Reiterated at Overweight by Cantor Fitzgerald September 22, 2026 8:13 AM - StreetInsider TD Cowen Starts Arcus Biosciences (RCUS) at Buy September 16, 2026 5:30 AM - StreetInsider Arcus Biosciences (RCUS) Reiterated at Overweight by Cantor Fitzgerald After CFO Chat September 11, 2026 7:03 AM - StreetInsider Arcus Biosciences Announces New Employment Inducement Grants September 9, 2026 4:35 PM - BizWire Arcus Biosciences (RCUS) PT Raised to $40 at Truist Securities September 8, 2026 7:15 AM - StreetInsider Arcus Biosciences to Participate in Three Upcoming Investor Conferences August 26, 2026 4:05 PM - BizWire Form 4 Arcus Biosciences, Inc. For: Aug 21 Filed by: Azoy Alexander August 24, 2026 5:52 PM - SEC Filing Form 144 Arcus Biosciences, Inc. Filed by: Azoy Alexander August 21, 2026 4:37 PM - SEC Filing Arcus Biosciences Announces New Employment Inducement Grants August 11, 2026 4:35 PM - BizWire Arcus Biosciences (RCUS) PT Raised to $23 at Morgan Stanley August 10, 2026 8:35 AM - StreetInsider Form SCHEDULE 13D/A Arcus Biosciences, Inc. Filed by: GILEAD SCIENCES, INC. August 7, 2026 4:30 PM - SEC Filing Arcus Biosciences (RCUS) PT Raised to $26 at Wells Fargo August 6, 2026 6:38 AM - StreetInsider Arcus Biosciences (RCUS) Tops Q2 EPS by 18c August 5, 2026 4:51 PM - StreetInsider Form 10-Q Arcus Biosciences, Inc. For: Jun 30 August 5, 2026 4:16 PM - SEC Filing Form 8-K Arcus Biosciences, Inc. For: Aug 05 August 5, 2026 4:11 PM - SEC Filing Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update August 5, 2026 4:05 PM - BizWire Arcus Biosciences Announces New Employment Inducement Grants July 27, 2026 4:35 PM - BizWire H.C. Wainwright Reiterates Buy Rating on Arcus Biosciences (RCUS) July 23, 2026 7:11 AM - StreetInsider Full Article List